CA2015315A1 - Improved method of blood component decontamination by glucose addition and post-decontamination gassing - Google Patents

Improved method of blood component decontamination by glucose addition and post-decontamination gassing

Info

Publication number
CA2015315A1
CA2015315A1 CA002015315A CA2015315A CA2015315A1 CA 2015315 A1 CA2015315 A1 CA 2015315A1 CA 002015315 A CA002015315 A CA 002015315A CA 2015315 A CA2015315 A CA 2015315A CA 2015315 A1 CA2015315 A1 CA 2015315A1
Authority
CA
Canada
Prior art keywords
decontamination
gassing
post
improved method
blood component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002015315A
Other languages
French (fr)
Other versions
CA2015315C (en
Inventor
Gary P. Wiesehahn
Laurence Corash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/350,335 external-priority patent/US5176921A/en
Application filed by Individual filed Critical Individual
Publication of CA2015315A1 publication Critical patent/CA2015315A1/en
Application granted granted Critical
Publication of CA2015315C publication Critical patent/CA2015315C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Biological compositions are freed of functional polynucleotides by treatment of the biological composition with psoralen derivatives under irradiation conditions in which the proteins retain their original physiological activities and any polynucleotide present is rendered inactive.
CA 2015315 1989-05-11 1990-04-24 Improved method of blood component decontamination by glucose addition and post-decontamination gassing Expired - Lifetime CA2015315C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/350,335 US5176921A (en) 1983-05-02 1989-05-11 Method of blood component decontamination by glucose addition
US07/350,335 1989-05-11

Publications (2)

Publication Number Publication Date
CA2015315A1 true CA2015315A1 (en) 1990-11-11
CA2015315C CA2015315C (en) 2001-03-06

Family

ID=23376261

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2015315 Expired - Lifetime CA2015315C (en) 1989-05-11 1990-04-24 Improved method of blood component decontamination by glucose addition and post-decontamination gassing

Country Status (1)

Country Link
CA (1) CA2015315C (en)

Also Published As

Publication number Publication date
CA2015315C (en) 2001-03-06

Similar Documents

Publication Publication Date Title
AU563557B2 (en) Photochemical decontamination treatment of whole blood or blood components
CA2019580A1 (en) Novel methods of treatment using ranolazine and related piperazine derivatives
EP0205579A4 (en) Methods and compositions useful in the diagnosis and treatment of autoimmune diseases.
NO175616C (en) Mix for stimulating hair growth
ES8600613A1 (en) Body implants of extracellular matrix and means and methods of making and using such implants.
AU7818487A (en) Intermittent aeration type biological treatment process and system therefor
CA2169173A1 (en) Methods for stimulating erythropoiesis using thrombopoietin
EP0506893A4 (en) Diagnosis and treatment of diseases
HU902004D0 (en) New trombolitic preparations
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
AU3861989A (en) Method for the treatment and the diagnosis of coronary heart disease
AU5413490A (en) Photochemical treatment of blood vessels
CA2015315A1 (en) Improved method of blood component decontamination by glucose addition and post-decontamination gassing
DE69014501D1 (en) Process for the treatment of titanium alloy and piece made therewith.
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
EP0436717A4 (en) Method of treatment with medical agents
EP0200527A3 (en) Norfloxacin salt
Begum et al. The pH dependent inhibitory effect of dieldrin on succinate dehydrogenase activity in fish Tilapia mossambica.
SU645647A1 (en) Method of lobe-wise cutout of liver from blood circulation
DE68902569D1 (en) METHODS AND PREPARATIONS FOR THE TREATMENT OF NIDDM.
Kozlovskaya et al. Acetyl cholinesterase activity in the brain and collagen content in the vertebra of goldfish exposed to chlorofos.
AU6997287A (en) The application of tissue plasminogen activator and oxypurinol in dissolving blood clots and in preventing damage to ischaemic tissue during reperfusion
OA08911A (en) Diagnosis and treatment of double-stranded RNA deficiency states.
IL90867A0 (en) Method of non-invasive determination of glucose in the blood

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry